Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer: A Prospective Randomized Open Blinded End-Point (Probe) Study

NCT03045406 is registered in ClinicalTrials.gov with Fadoi Foundation, Italy as lead sponsor.

NCT NCT03045406
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03045406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer: A Prospective Randomized Open Blinded End-Point (Probe) Study
Lead sponsor
Fadoi Foundation, Italy
Phase
Phase 3
Overall status
Completed
Start date
April 13, 2017
Completion date
December 1, 2019
Enrollment
1,170 (actual)
Sites
127

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism